Oric Pharmaceuticals, Inc. ORIC Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s total equity?
- Oric Pharmaceuticals, Inc. (ORIC) reported total equity of $415.56M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Oric Pharmaceuticals, Inc.'s total equity increased by 89.1% year-over-year, from $219.74M to $415.56M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s total equity has grown at a 5.8% compound annual growth rate (CAGR), from $289.78M to $384.36M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.